Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Apoptosis ; 19(5): 829-40, 2014 May.
Article in English | MEDLINE | ID: mdl-24395041

ABSTRACT

Brain and Reproductive Organ Expressed (BRE), or BRCC45, is a death receptor-associated antiapoptotic protein, which is also involved in DNA-damage repair, and K63-specific deubiquitination. BRE overexpression attenuates both death receptor- and stress-induced apoptosis, promotes experimental tumor growth, and is associated with human hepatocellular and esophageal carcinoma. How BRE mediates its antiapoptotic function is unknown. Here we report based on the use of a mouse Lewis lung carcinoma cell line D122 that BRE has an essential role in maintaining the cellular protein level of XIAP, which is the most potent endogenous inhibitor of the caspases functioning in both extrinsic and intrinsic apoptosis. shRNA-mediated exhaustive depletion of BRE sensitized D122 cells to apoptosis induced not only by etopoxide, but also by TNF-α even in the absence of cycloheximide, which blocks the synthesis of antiapoptotic proteins by TNF-α-activated NF-κB pathway. In BRE-depleted cells, protein level of XIAP was downregulated, but not the levels of other antiapoptotic proteins, cIAP-1, 2, and cFLIP, regulated by the same NF-κB pathway. Reconstitution of BRE restored XIAP levels and increased resistance to apoptosis. XIAP mRNA level was also reduced in the BRE-depleted cells, but the level of reduction was less profound than that of the protein level. However, BRE could not delay protein turnover of XIAP. Depletion of BRE also increased tumor cell apoptosis, and decreased both local and metastatic tumor growth. Taken together, these findings indicate that BRE and its XIAP-sustaining mechanism could represent novel targets for anti-cancer therapy.


Subject(s)
Apoptosis/physiology , Carcinoma, Lewis Lung/metabolism , Caspase Inhibitors/metabolism , Nerve Tissue Proteins/metabolism , X-Linked Inhibitor of Apoptosis Protein/metabolism , Animals , Carcinoma, Lewis Lung/pathology , Cell Line, Tumor , Cell Proliferation , Mice , Mice, Inbred C57BL , Nuclear Proteins , X-Linked Inhibitor of Apoptosis Protein/genetics
2.
Diagn Microbiol Infect Dis ; 62(2): 142-50, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18715736

ABSTRACT

We described a 5-min colorimetric test for paratyphoid A fever, which detects anti-Salmonella O2 antibodies by inhibiting the binding between 2 types of reagent particles. This test (TUBEX-PA) is based on that (TUBEX-TF) used for typhoid fever, which detects anti-O9 antibodies. TUBEX-PA showed a sensitivity of 81.0% (47/58 culture-confirmed patients) to 93.3% (14/15) and was 98.1% (52/53) specific for healthy subjects. However, TUBEX-PA also detected 50% (7/14) to 81.8% (9/11) of typhoid patients, and conversely, TUBEX-TF detected 46.7% (7/15) to 73.3% (11/15) of paratyphoid A cases. This cross-detection could be abrogated in both tests by adding a blocker (heterologous antigen) to remove the antibodies responsible, which presumably bind to a common antigen (O12) located close to O2 and O9. The presence of anti-O12 antibodies in typhoid (9/12 or 75.0% sensitive) and paratyphoid A (22/33 or 66.7%) patients was demonstrated directly using a prototypic TUBEX test designed specifically to detect these antibodies. Thus, using TUBEX-PA and TUBEX-TF together can increase the diagnostic accuracy of detecting both typhoid and paratyphoid A fever, while the further use of differential tests allows possible immediate discrimination between these diseases.


Subject(s)
Antibodies, Bacterial/blood , Colorimetry/methods , O Antigens/immunology , Paratyphoid Fever/diagnosis , Reagent Kits, Diagnostic , Salmonella paratyphi A/immunology , Adolescent , Adult , Child , Child, Preschool , Humans , Immunoassay , Middle Aged , Paratyphoid Fever/microbiology , Salmonella paratyphi A/classification , Serotyping , Time Factors
3.
J Immunol ; 181(3): 2246-57, 2008 Aug 01.
Article in English | MEDLINE | ID: mdl-18641365

ABSTRACT

It is puzzling how autoreactive B cells that escape self-tolerance mechanisms manage to produce Abs that target vital cellular processes without succumbing themselves to the potentially deleterious effects of these proteins. We report that censorship indeed exists at this level: when the Ab synthesis in the cell is up-regulated in IL-6-enriched environments (e.g., adjuvant-primed mouse peritoneum), the cell dies of the increased intracellular binding between the Ab and the cellular autoantigen. In the case in which telomerase is the autoantigen, mouse hybridoma cells synthesizing such an autoantibody, which appeared to grow well in culture, could not grow in syngeneic BALB/c mice to form ascites, but grew nevertheless in athymic siblings. Culture experiments demonstrated that peritoneal cell-derived IL-6 (and accessory factors) affected the growth and functions of the hybridoma cells, including the induction of mitochondria-based apoptosis. Electron microscopy revealed an abundance of Abs in the nuclear chromatin of IL-6-stimulated cells, presumably piggy-backed there by telomerase from the cytosol. This nuclear presence was confirmed by light microscopy analysis of isolated nuclei. In two other cases, hybridoma cells synthesizing an autoantibody to GTP or osteopontin also showed similar growth inhibition in vivo. In all cases, Ab function was crucial to the demise of the cells. Thus, autoreactive cells, which synthesize autoantibodies to certain intracellular Ags, live delicately between life and death depending on the cytokine microenvironment. Paradoxically, IL-6, which is normally growth-potentiating for B cells, is proapoptotic for these cells. The findings reveal potential strategies and targets for immunotherapy.


Subject(s)
Apoptosis/immunology , Autoantibodies/biosynthesis , Autoantibodies/immunology , B-Lymphocytes/immunology , B-Lymphocytes/pathology , Animals , Antibody Specificity/immunology , Apoptosis/drug effects , Ascites/genetics , Ascites/immunology , Autoantibodies/genetics , Autoantibodies/metabolism , Base Sequence , Cell Nucleus/immunology , Cell Nucleus/metabolism , Cells, Cultured , Humans , Hybridomas , Immunoglobulin G/immunology , Immunoglobulin M/immunology , Interleukin-6/pharmacology , Mice , Microscopy, Immunoelectron , Mitochondria/immunology , Mitochondria/metabolism , Molecular Sequence Data , Telomerase/immunology , Telomerase/metabolism
4.
J Immunol Methods ; 321(1-2): 152-63, 2007 Apr 10.
Article in English | MEDLINE | ID: mdl-17331532

ABSTRACT

Bacterially-produced antibody fragments, such as single-chain Fv (scFv) which comprises the variable regions of the light (VL) and heavy (VH) chains joined together by a short flexible linker, are useful as diagnostic and therapeutic agents. We previously constructed a scFv fragment from a hybridoma antibody (Mab2) but it unexpectedly lacked the unique carrier specificity of the native antibody. Thus, it bound indiscriminately to various phosphorylcholine (PC)-associated antigens, whereas the hybridoma antibody recognized the PC epitope only in the context of the immunizing antigen. Here, we investigated whether the problem was linker-related by changing the linker composition or by deleting it, but these attempts proved futile. Instead, we have constructed a recombinant Fab fragment of the antibody in bacteria that was carrier-specific. This suggests that constant regions are required for the carrier specificity, which presumably helps to mould the fine structure of the antibody combining site or in stabilizing such a structure. Consistent with this global effect is the finding that replacing specific residues in VH with germ-line residues, namely, VH49 glycine and VH30 threonine, both thought previously to be important for the carrier specificity, had no effect on the carrier specificity of the recombinant Fab.


Subject(s)
Antibodies, Helminth/chemistry , Antigens, Helminth/immunology , Haptens/immunology , Immunoglobulin Fab Fragments/chemistry , Phosphorylcholine/immunology , Trichinella spiralis/immunology , Amino Acid Sequence , Animals , Antibodies, Helminth/genetics , Antibodies, Helminth/metabolism , Antibody Specificity , Antigens, Helminth/metabolism , Binding Sites, Antibody , Glycine/chemistry , Haptens/metabolism , Immunoglobulin Fab Fragments/genetics , Immunoglobulin Fab Fragments/metabolism , Immunoglobulin Variable Region/chemistry , Molecular Sequence Data , Mutation , Phosphorylcholine/metabolism , Protein Conformation , Recombinant Proteins/chemistry , Threonine/chemistry , Trichinella spiralis/metabolism
5.
Histochem Cell Biol ; 123(1): 105-12, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15538612

ABSTRACT

Telomerase is an important tumor marker but few antibodies to the enzyme have been described or used without difficulty in histochemical detection. Here we report specific detection of the enzyme in cell and tissue preparations using a new monoclonal antibody (mAb 476) and a new antigen-retrieval buffer (Enhancing buffer). When used to detect telomerase under normal immunostaining conditions in HL-60 cells or tissue sections of hepatocellular carcinoma or metastatic choriocarcinoma, unexpectedly, the antibody stained the cytoplasm rather than the nucleus. Nuclear staining, however, was revealed using the Enhancing buffer. Since other nuclear antigens in the HL-60 cell could be stained both ordinarily and in the Enhancing buffer, nuclear telomerase appears to be shrouded by the nuclear matrix or blocked by accessory proteins. The cytoplasmic activity seen in normal buffer but absent largely from the Enhancing buffer may be an artifact or the nascent, "naked" enzyme. With a known cytoplasmic antigen (proteinase-3) chosen arbitrarily for comparison, the antigenicity was found enhanced, instead, by the Enhancing buffer. The mode of action of the Enhancing buffer differs from that of microwave irradiation or the signal amplification (CSA) used by some investigators. The latter was found to enhance the cytoplasmic reactivity rather than the nuclear reactivity of mAb 476.


Subject(s)
Antibodies, Monoclonal/immunology , Biomarkers, Tumor/immunology , Cell Nucleus/enzymology , Telomerase/immunology , Animals , Antibody Specificity , Buffers , Carcinoma, Hepatocellular/enzymology , Carcinoma, Hepatocellular/pathology , Cell Nucleus/immunology , Choriocarcinoma/enzymology , Choriocarcinoma/secondary , Cytoplasm/enzymology , Cytoplasm/immunology , Epitopes , HL-60 Cells , Humans , Immunohistochemistry , Intestinal Neoplasms/enzymology , Intestinal Neoplasms/secondary , Liver Neoplasms/enzymology , Liver Neoplasms/pathology , Mice , Mice, Inbred BALB C , RNA, Messenger , Telomerase/genetics
6.
J Infect Dis ; 190(2): 379-86, 2004 Jul 15.
Article in English | MEDLINE | ID: mdl-15216476

ABSTRACT

The recent outbreak of severe acute respiratory syndrome (SARS) provided an opportunity to study the antibody response of infected individuals to the causative virus, SARS coronavirus. We examined serum samples obtained from 46 patients with SARS, 40 patients with non-SARS pneumonia, and 38 healthy individuals, by use of Western blotting (WB), enzyme-linked immunoassay (ELISA), and immunofluorescence assay, using both native and bacterially produced antigens of the virus. We found a highly restricted, immunoglobulin G-dominated antibody response in patients with SARS, directed most frequently (89% by ELISA) and predominantly at the nucleocapsid. Almost all of the subjects without SARS had no antinucleocapsid antibodies. The spike protein was the next most frequently targeted, but only 63% of the patients (by ELISA) responded. Other targets of the response identified by use of WB included antigens of 80 and 60 kDa. Several nonstructural proteins cloned were not antigenic, and the culture-derived nucleocapsid appeared to be specifically degraded.


Subject(s)
Antibodies, Viral/blood , Nucleocapsid/immunology , Severe Acute Respiratory Syndrome/immunology , Severe acute respiratory syndrome-related coronavirus/immunology , Adolescent , Adult , Aged , Antigens, Viral/immunology , Blotting, Western , Child , Enzyme-Linked Immunosorbent Assay , Female , Fluorescent Antibody Technique, Indirect , Humans , Immunoglobulin G/blood , Male , Membrane Glycoproteins/immunology , Middle Aged , Molecular Weight , Severe Acute Respiratory Syndrome/virology , Spike Glycoprotein, Coronavirus , Viral Envelope Proteins/immunology
7.
Arthritis Rheum ; 50(5): 1533-8, 2004 May.
Article in English | MEDLINE | ID: mdl-15146423

ABSTRACT

OBJECTIVE: To investigate why the serum of a pediatric patient with systemic lupus erythematosus was persistently (>30 months) and strongly positive for antibodies to double-stranded DNA (dsDNA) as revealed by enzyme-linked immunosorbent assay (ELISA), but yielded negative results on the antinuclear antibody test (HEp-2 immunofluorescence [IF]). METHODS: The patient's antibodies were isolated on dsDNA and single-stranded DNA (ssDNA) supports, which were then examined by dsDNA ELISA and HEp-2 IF. Tests included the use of various inhibitors to determine the fine specificity of the antibodies. Other tests performed included immunoblotting, immunoprecipitation, Crithidia luciliae IF, and neutrophil IF. RESULTS: The antibodies isolated from the dsDNA and ssDNA supports were similar, in that they were of the IgG type, bound well in the dsDNA ELISA, and recognized a normally hidden nucleolar RNA antigen in HEp-2 cells. With both the dsDNA ELISA and nucleolar antigens, inhibition studies revealed that the epitope recognized was guanosine 5'-triphosphate (GTP). Binding of the antibodies was better to GTP than to guanosine 5'-monophosphate or cytidylyl (3'-5') guanosine, and, in turn, was better than to guanosine, while N7-methylated GTP was unreactive. The antibodies did not bind to dsDNA present in solution or in HEp-2 or Crithidia cells, but bound transfer RNA well and recognized a cytoplasmic RNA antigen in neutrophils. CONCLUSION: A new problem in dsDNA ELISA is revealed in the occurrence of a hitherto-unknown and unusual buckling of the insolubilized DNA molecule, which, absent in dsDNA found in solution or in whole cells, presumably creates gaps of single-strandedness in the molecule. A new antibody specific for GTP is described in this patient, which may be clinically important.


Subject(s)
Antibodies, Antinuclear/blood , DNA/immunology , Enzyme-Linked Immunosorbent Assay/standards , Guanosine Triphosphate/immunology , Lupus Erythematosus, Systemic/immunology , Antibody Specificity , Child , DNA/metabolism , False Positive Reactions , Female , Humans , Lupus Erythematosus, Systemic/diagnosis , Solubility
8.
J Bone Miner Metab ; 22(2): 148-52, 2004.
Article in English | MEDLINE | ID: mdl-14999526

ABSTRACT

Transforming growth factor-beta-1 (TGF-Beta(1)) has been implicated in bone mineral density (BMD) determination. We investigated the relationship between the TGF polymorphism, BMD, and vertebral fractures in 588 Chinese men and women. No association between TGF polymorphism and BMD was observed in postmenopausal women (aged 55-59 years), elderly men (aged 70-79 years), or elderly women (aged 70-79 years) at the hip, spine, or total body ( P >> 0.05 by two-way ANOVA). In all study groups, there was no effect of an interaction between TGF polymorphism and calcium intake on BMD ( P >> 0.05 for the interaction effects by two-way ANOVA). No statistical significant association was observed between TGF polymorphism and vertebral fracture in elderly men or women ( P >> 0.05 by the chi-square test), even though men of the TT and TC genotypes seem to have more vertebral fractures. Contrary to previous studies that found an association between BMD and TGF polymorphism in the Japanese, we found no association between TGF polymorphism and BMD of elderly Chinese men or women. This finding could result from different sampling methods between the previous and current studies and environmental factors and ethnic differences between the two populations.


Subject(s)
Bone Density , Osteoporosis/genetics , Polymorphism, Genetic , Transforming Growth Factor beta/genetics , Aged , Calcium, Dietary , China , Female , Genotype , Hip/diagnostic imaging , Humans , Male , Middle Aged , Osteoporosis/metabolism , Radiography , Spinal Fractures , Spine/diagnostic imaging , Statistics as Topic , Transforming Growth Factor beta1
SELECTION OF CITATIONS
SEARCH DETAIL
...